Circular RNA MYLK as a prognostic biomarker in patients with cancers: A systematic review and meta-analysis.

CircMYLK is involved in the progression of numerous cancers via different signaling pathways. This circRNA can serve as a promising prognostic biomarker for several types of malignancies. Furthermore, high expression of circMYLK is associated with advanced clinicopathological characteristics in various tumors.